Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23301739)

1.

Discontinuation of risperidone in Alzheimer's disease.

Power GA.

N Engl J Med. 2013 Jan 10;368(2):186-7. doi: 10.1056/NEJMc1214030#SA2. No abstract available.

PMID:
23301739
2.

An unsubstantiated conclusion.

Reifler BV, Blazer D.

Am J Geriatr Psychiatry. 2015 Feb;23(2):220. doi: 10.1016/j.jagp.2014.07.010. Epub 2014 Oct 15. No abstract available.

PMID:
25575935
3.

Licensed indication for risperidone in dementia.

Phizackerley D.

BMJ. 2014 Dec 10;349:g7337. doi: 10.1136/bmj.g7337. No abstract available.

PMID:
25498536
4.

Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.

Corbett A, Burns A, Ballard C.

BMJ. 2014 Nov 3;349:g6420. doi: 10.1136/bmj.g6420. No abstract available.

PMID:
25368388
5.

Vaginal application of orodispersible drugs for schizophrenia presenting with agitation and aggression.

Abrahamowicz C, Huber J, Zimmermann T, Huber CG.

Acta Psychiatr Scand. 2015 Apr;131(4):318-9. doi: 10.1111/acps.12337. Epub 2014 Sep 13. No abstract available.

PMID:
25219417
6.

Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.

Bogaisky M.

Am J Geriatr Psychiatry. 2014 Sep;22(9):951. doi: 10.1016/j.jagp.2014.04.010. Epub 2014 Jun 2. No abstract available.

PMID:
25109421
7.

Response to Bogaiksy's letter to the editor.

Freund-Levi Y, Jedenius E, Wahlund LO, Eriksdotter M, Tysen-Bäckström AC, Lärksäter M.

Am J Geriatr Psychiatry. 2014 Sep;22(9):951. doi: 10.1016/j.jagp.2014.05.010. Epub 2014 Jun 2. No abstract available.

PMID:
25109420
8.

Calming Alzheimer's agitation: a promising drug.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2014 Jun;29(5):8. No abstract available.

PMID:
25097959
9.

Prognosis of a brief psychotic episode.

Furukawa TA.

Evid Based Ment Health. 2014 Aug;17(3):81-2. doi: 10.1136/eb-2014-101898. No abstract available.

PMID:
25043433
10.

Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.

Underwood BR, Fox C.

Evid Based Med. 2014 Oct;19(5):181. doi: 10.1136/ebmed-2014-110016. Epub 2014 May 13. No abstract available.

PMID:
24824622
11.

Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.

Raskind MA, Wang LY.

Int Psychogeriatr. 2014 Jun;26(6):879-83. doi: 10.1017/S1041610214000477. Epub 2014 Apr 4. No abstract available.

PMID:
24703502
12.

Response to Carnahan.

Lopez OL, Becker JT.

Am J Psychiatry. 2014 Feb;171(2):227-8. doi: 10.1176/appi.ajp.2013.13091231r. No abstract available.

PMID:
24500461
13.

Challenges in estimating mortality risk from antipsychotics in people with Alzheimer's disease.

Carnahan RM.

Am J Psychiatry. 2014 Feb;171(2):227. doi: 10.1176/appi.ajp.2013.13091231. No abstract available.

PMID:
24500460
14.

Psychosis, agitation, and antipsychotic treatment in dementia.

Devanand DP.

Am J Psychiatry. 2013 Sep;170(9):957-60. doi: 10.1176/appi.ajp.2013.13060767. No abstract available.

PMID:
24030608
15.

Discontinuation of risperidone in Alzheimer's disease.

Ling SM, Bonner AF, McMullen TL.

N Engl J Med. 2013 Jan 10;368(2):187. doi: 10.1056/NEJMc1214030#SA3. No abstract available.

PMID:
23301740
16.

Discontinuation of risperidone in Alzheimer's disease.

Gnjidic D, Hilmer SN.

N Engl J Med. 2013 Jan 10;368(2):186. doi: 10.1056/NEJMc1214030#SA1. No abstract available.

PMID:
23301738
17.

Discontinuation of risperidone in Alzheimer's disease.

Devanand DP, Schultz SK, Sultzer DL.

N Engl J Med. 2013 Jan 10;368(2):187-8. doi: 10.1056/NEJMc1214030. No abstract available.

18.

[Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].

Förstl H.

Dtsch Med Wochenschr. 2013 Jan;138(1-2):16. doi: 10.1055/s-0032-1329031. Epub 2012 Dec 18. German. No abstract available.

PMID:
23250689
19.

Relapse risk after discontinuation of risperidone in Alzheimer's disease.

Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B.

N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058. Erratum in: N Engl J Med. 2012 Dec 20;367(25):2458.

20.

[Postpartum psychosis associated with cabergoline].

Salinas Botrán A, Urgelés Puértolas D, Peregrin Abad E.

Med Clin (Barc). 2013 Jan 5;140(1):45-6. doi: 10.1016/j.medcli.2012.05.003. Epub 2012 Jul 4. Spanish. No abstract available.

PMID:
22766049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk